Applied Physiology: Lecture 8 - Resp Phys 3 Flashcards
(59 cards)
CLOSING CAPACITY
What is Closing Capacity? (KNOW CLOSING CAPACITY!!!)
Remember that all “capacities” are the summation of other volumes
Closing Capacity = Closing Volume + Residual Volume
Closing Volume = the volume of air in the lungs at which the airways in the dependent portion (lowesetportion of lung most influenced by gravity) of the lung begin to close / collapse.
Residual Volume = the volume of air in the lungs following a maximum exhalation.
CLOSING CAPACITY (WHAT IT LOOKS LIKE)
CLOSING CAPACITY (WHAT IT LOOKS LIKE)
This is purely a “graphical
representation”
The line at which airway closure
begins may occur at volumes less than FRC (as seen here) or…
CLOSING CAPACITY (WHAT IT LOOKS LIKE)
This is purely a “graphical
representation”
The line at which airway closure begins
may occur at volumes less than FRC (as seen here) or …
Closure might occur at higher volumes
(like in the diseased lung)
Less than Ideal when closing capacity is
greater than FRC… airways close before you even fill up your lungs
CLOSING CAPACITY (HOW WE MEASURE IT)
Single Breath (Nitrogen) N
2washout method.
Patient is breathing room air (approx. 79%
N2)
Then we have the patient take a vital
capacity breath of 100% O2.
We then measure the N2 concentration at the lips on the subsequent exhalation
The concentration of the N2 is measured and recognized in 4 phases.
CLOSING CAPACITY (HOW WE MEASURE IT)
Phase 1
Pure dead space
Phase 2
Mixture of dead space & alveolar gas
Phase 3
Pure alveolar gas
Phase 4
Occurs at near the end of expiration. It is signified by a sharp increase in N2 concentration.
Why?
Who can explain to the class why we see a sharp increase in N2at the end of expiration?
CLOSING CAPACITY (HOW WE MEASURE IT) PHASE 4
Phase 4 explanation can be thinking about the
portion of the lungs that are best ventilated during a vital capacity.
The apex of the lungs are almost certainly
always “open” or expanded, so during a vital capacity they won’t expand much. Therefore they don’t take in much of the 100% O2 and they contain a lot of N2 from previous breaths.
The late N2 rise is due to collapse (closure) of the dependent regions of the lung and now exhalation is occurring primarily from the apex of the lungs.
This sharp increase in the N2 marks the point where we can calculate the closing volume.
CLOSING CAPACITY (WHY DOES IT MATTER?)
A young person will have a closing volume
that is approx. 10% of their vital capacity.
As we age, our closing volume increases
(hence, so will our closing capacity)
At age 65yrs, our closing capacity is
approximately the same as our FRC.
CLOSING CAPACITY (DISEASE STATES)
Certain Diseases Increase Closing Capacity
COPD
Asthma
Pulmonary Edema
Obesity?
Actually does NOT increase the closing capacity, but it does decrease the patient’s FRC.
So closing capacity will approach FRC earlier in life.
DISEASED LUNGS PATHOPHYSIOLOGY
Obstructive Lung Diseases
(Can’t Exhale)
Reduced elasticity or premature
closure of small airways and decreased ventilation. Such as…
COPD
Emphysema
Chronic Bronchitis
Asthma
Usually a temporary obstruction that is reversible due to inflammation of airways.
Restrictive Lung Disease
(Can’t Inhale)
Reduced lung volumes due to
damage to the lung tissue itself or structural change/weakness of the thorax. Classified broadly as…
Intrinsic –pathology with the lung parenchyma (ex. Pulmonary fibrosis)
Extrinsic –chest wall or pleura dysfunction (ex. Severe scoliosis AS)
Cystic Fibrosis is obstructive (WHAT IS THE OTHER ONE???)
DISEASED LUNGS (LIST YOU NEED TO KNOW)
Obstructive Lung Diseases
(Can’t Exhale)
COPD
Chronic Bronchitis –aka the blue bloater
Emphysema –aka the pink puffer
Asthma
Bronchiectasis
Cystic Fibrosis
Restrictive Lung Disease
(Can’t Inhale)
Obesity
Pulmonary Fibrosis (stiff lungs)
Scoliosis (severe)
Neuromuscular disease
ALS (aka Lou Gehrig’s disease)
Muscular dystrophy
Myasthenia Gravis
Sarcoidosis
Auto-immune diseases
Blue Bloater vs Pink Puffer
DISEASED LUNGS (DIFFERENTIATING THE TWO WITH PFT RESULTS)
Obstructive Lung Diseases
(Can’t Exhale)
Restrictive Lung Disease
(Can’t Inhale)
DISEASED LUNGS (DIFFERENTIATING THE TWO)
Obstructive Lung Diseases
(Can’t Exhale)
Restrictive Lung Disease
(Can’t Inhale)
DLCO (Perfusion capacity of carbon monoxide)
One must remember that DLCO is really a function of how well a gas transitions from the alveoli to the blood stream. If you have less alveolar surface area (like in severe emphysema) less CO can be taken up by the blood. Therefore the DLCO in emphysema would be low.
Low DLCO
Conditions that decrease effective alveolar surface area.
COPD / Emphysema (less alveolar surface area), Restrictive lung diseases (less lung volume/area), decreased effective blood supply to lungs (CHF and anemia), drug pulmonary toxicity (bleomycin, amiodarone)
Normal to High DLCO
Asthma, Polycythemia (increased Hgb), L→R intra-cardiac shunt, alveolar hemorrhage.
DISEASED LUNGS (DIFFERENTIATING THE TWO)
DLCO Changes –More Complete list
DISEASED LUNGS (PERI-OP MANAGEMENT / OPTIMIZATION)
Obstructive Lung Diseases
(Can’t Exhale)
Preoperative Bronchodilator
Albuterol
Preoperative Steroids
Solu-Medrol
Anti-cholinergic
Ipratroprium
Warm & Humidify Air
(HME)
Increase the I:E ratio
(provide longer for exhalation)
Avoid Hyperventilation
Allow some permissive hypercapnia
Restrictive Lung Disease
(Can’t Inhale)
Avoid “elective procedures” in settings of acute respiratory events. (Don’t do a face lift just after the patient aspirates)
If smoker – get them to stop (even 24hrs and reducing carboxyhemoglobin will help these patients)
Decreased compliance – may require increased PEEP, increased RR & increased FiO2 to oxygenate.
May require post-op ventilation
Treat their pain – obviously don’t oversedate, but they need their pain treated to prevent splinting.
WHAT IS ASTHMA?
Asthma is a chronic inflammatory disease characterized by obstruction of the airways that is partially or completely reversible with treatment or spontaneously.
Bronchoconstriction is precipitated by irritants….
Wheezing is a common symptom in asthmatics but is not specific for this disease. Patients with chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease, vocal cord dysfunction, tracheal or bronchial stenosis, cystic fibrosis, allergic bronchopulmonary aspergillosis, and heart failure may wheeze.
Spirometry is the preferred diagnostic test, but a normal result does not exclude asthma
PFTs have no perioperative predictive value but in rare instances may be useful to gauge the severity of disease or the adequacy of therapy
Typical findings on PFTs are reduced forced expiratory volume in 1 second (FEV1)
WHAT IS COPD
COPD includes chronic bronchitis and emphysema and is characterized by obstruction to airflow that is not fully reversible (main cause: increased resistance)
Caused by environment, a1-antitrypsin deficiency, chronic infections, and long-standing asthma
Dyspnea, coughing, wheezing, and sputum production are common features
A barrel chest and pursed-lip breathing suggest advanced disease.
Typically, FEV1 is reduced because of obstructed airflow, but FVC is increased because of reduced airflow, loss of elasticity, and overexpansion
Diffusing capacity (DLCO) is typically decreased
PFTs have not been shown to predict perioperative outcome
ECG may demonstrate right axis deviation, RBBB, or peaked P waves, which suggest pulmonary hypertension and possibly right ventricular changes in response to the chronic lung disease
Chronic hypoxia leads to polycythemia and respiratory acidosis
COPD- CLOSING CAPACITY
Airway closure occurs at higher lung volumes in patients with obstructive lung disease, asthma and lung edema edema
Any process that increases the CC by increasing the functional residual capacity (FRC) can increase an individual’s risk of hypoxemia, as the small airways may collapse during exhalation, leading to air trapping and atelectasis.
Airways collapse during normal breathing
COPD
Normal physiological drive to breathe is related to CO2 levels in the blood
COPD patients are accustomed to elevated CO2 levels.
COPD patients ventilate in response to Hypoxia.
What do you think will happen to a COPD patient receiving 1OL O2 Satting 99% in PACU? Could depress their respiratory drive to CO2, they are no driven by O2
You may want to maintain O2 sats in the low 90s vs higher.
COPD-BULLAE
Many patients with moderate or
severe COPD will develop cystic air spaces in the lung parenchyma known as bullae.
Remember:
Volumetrauma associated with increased incidence of pneumothorax in normal lung
COPD: Barotrauma associated with
increased incidence of pneumothorax
Keep Plateau pressured under 35mmHG
Volume = cause of pneuos in normal, healthy
Baro = cause of pneuos in COPDers… thus the keep pressure under 35 mmHg
(What is the TRANSPULMONARY PRESSURE???? LOOK UP!!!)
COPD POINTS
Severe COPD patients are often “flow limited” even during tidal volume expiration at rest
Flow limitation occurs particularly in emphysematous patients, who primarily have a problem with loss of lung elastic recoil and have marked dyspnea on exertion.
Severely flow-limited patients are at risk for hemodynamic collapse with the application of positive-pressure ventilation owing to dynamic hyperinflation of the lungs.
Auto-PEEP has been found to develop in most COPD patients during one-lung anesthesia
Pulmonary complications are decreased in thoracic surgical patients who cease smoking for
more than 4 weeks before surgery.
Carboxyhemoglobin concentrations decrease if smoking is stopped more than 12 hours.
Cessation of smoking, ABX for purulent sputum, Chest physiotherapy, Nebulizers all decrease morbidity in the Periop period
8 weeks or more of smoking cessation was associated with a 66% reduction in
postoperative pulmonary complications
Incentive spirometry and deep breathing before abdominal surgery had more than a
50% lower incidence of clinical complications
Bronchectasis
Chronic lung issue where lung tissue is scarred, and persistant buildup of mucus
Non curable
Focus on treatment modalities
Recurrent lung/bronchial infections is the primary culprit and cause
Treatment included: ABX, chest physiotherapy, inhlaers
DISEASED LUNGS (SPECIAL CASE – CUTTING OUT SOME LUNG & DETERMINING WHO WILL TOLERATE IT AND WHO WON’T)
Calculating the post-operative pulmonary function in a patient undergoing thoracotomy and lung resection is important.
Three (3) cardiopulmonary function tests are important.
- The predicted post-operative FEV1 (ppoFEV1) assesses pulmonary mechanics.
- ppoDLCO assesses lung parenchymal function
- Preoperative VO2max assess interaction between cardiac and pulmonary function.